Literature DB >> 24375984

Top-down mass spectrometry imaging of intact proteins by laser ablation ESI FT-ICR MS.

András Kiss1, Donald F Smith, Brent R Reschke, Matthew J Powell, Ron M A Heeren.   

Abstract

Laser ablation ESI (LAESI) is a recent development in MS imaging. It has been shown that lipids and small metabolites can be imaged in various samples such as plant material, tissue sections or bacterial colonies without any sample pretreatment. Further, LAESI has been shown to produce multiply charged protein ions from liquids or solid surfaces. This presents a means to address one of the biggest challenges in MS imaging; the identification of proteins directly from biological tissue surfaces. Such identification is hindered by the lack of multiply charged proteins in common MALDI ion sources and the difficulty of performing tandem MS on such large, singly charged ions. We present here top-down identification of intact proteins from tissue with a LAESI ion source combined with a hybrid ion-trap FT-ICR mass spectrometer. The performance of the system was first tested with a standard protein with electron capture dissociation and infrared multiphoton dissociation fragmentation to prove the viability of LAESI FT-ICR for top-down proteomics. Finally, the imaging of a tissue section was performed, where a number of intact proteins were measured and the hemoglobin α chain was identified directly from tissue using CID and infrared multiphoton dissociation fragmentation.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Imaging mass spectrometry; Technology; Top-down proteomics

Mesh:

Substances:

Year:  2014        PMID: 24375984     DOI: 10.1002/pmic.201300306

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

1.  MALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics Data.

Authors:  Jeffrey M Spraggins; David G Rizzo; Jessica L Moore; Kristie L Rose; Neal D Hammer; Eric P Skaar; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-23       Impact factor: 3.109

Review 2.  Direct sampling mass spectrometry for clinical analysis.

Authors:  Fan Pu; Spencer Chiang; Wenpeng Zhang; Zheng Ouyang
Journal:  Analyst       Date:  2019-02-11       Impact factor: 4.616

Review 3.  Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions.

Authors:  Sarah J Parker; Koen Raedschelders; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2015-02-10       Impact factor: 3.984

4.  Increased throughput and ultra-high mass resolution in DESI FT-ICR MS imaging through new-generation external data acquisition system and advanced data processing approaches.

Authors:  Pieter C Kooijman; Konstantin O Nagornov; Anton N Kozhinov; David P A Kilgour; Yury O Tsybin; Ron M A Heeren; Shane R Ellis
Journal:  Sci Rep       Date:  2019-01-09       Impact factor: 4.379

5.  Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison.

Authors:  Lieke Lamont; Darya Hadavi; Brent Viehmann; Bryn Flinders; Ron M A Heeren; Rob J Vreeken; Tiffany Porta Siegel
Journal:  Anal Bioanal Chem       Date:  2021-03-26       Impact factor: 4.142

6.  Targeted Drug and Metabolite Imaging: Desorption Electrospray Ionization Combined with Triple Quadrupole Mass Spectrometry.

Authors:  Lieke Lamont; Gert B Eijkel; Emrys A Jones; Bryn Flinders; Shane R Ellis; Tiffany Porta Siegel; Ron M A Heeren; Rob J Vreeken
Journal:  Anal Chem       Date:  2018-11-06       Impact factor: 6.986

7.  Imaging Isomers on a Biological Surface: A Review.

Authors:  Britt S R Claes; Emi Takeo; Eiichiro Fukusaki; Shuichi Shimma; Ron M A Heeren
Journal:  Mass Spectrom (Tokyo)       Date:  2019-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.